Compound 3F is a reversible dual inhibitor of eeAChE and eqBuChE with IC50 values of 1.3 µM and 0.81 µM, respectively. It also exhibits anti-inflammatory activity and provides neuroprotection against Aβ25-35-induced toxicity in PC12 cells, supporting research in neurodegenerative disease models.